HIGHLIGHT
| Reference number | |
| Coordinator | GASPOROX AB (publ) |
| Funding from Vinnova | SEK 5 000 000 |
| Project duration | October 2024 - October 2026 |
| Status | Ongoing |
| Venture | Eurostars |
Important results from the project
HIGHLIGHT has largely achieved its technical objectives by developing a high-power diode laser, an advanced measurement module and an integrated system for rapid, non-destructive analysis of pharmaceutical tablets. The project has strengthened collaboration between Gasporox, Beamonics and nanoplus and established a foundation for commercialization. For Gasporox, the technology opens opportunities for a new business area in quality control of oral solid dosage forms.
Expected long term effects
The project lays the foundation for a new Gasporox business area in quality control of oral solid dosage forms, expanding its market and long-term growth potential. The technology could improve pharmaceutical manufacturing through rapid, non-destructive analysis, better process control and reduced material waste. The project also strengthens the company´s technical expertise and international competitiveness.
Approach and implementation
The project was carried out jointly by Gasporox, Beamonics and nanoplus, with clear responsibilities for the measurement system, electronics and laser technology. Development followed an iterative process of prototyping, integration, testing and optimization. Regular meetings ensured effective coordination. Some technical challenges required adjustments and further development, but the project largely progressed as planned. Collaboration between the partners worked well.